HALOZYME THERAPEUTICS, INC.: capex
| Value | {"amount": 10696000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:36:33.282397+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/defec8e5-f83a-4676-bae8-61a2a73570e0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-25-000010Retrieved: 2026-08-19T11:36:33.282397+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/capex/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/defec8e5-f83a-4676-bae8-61a2a73570e0
History
- no predecessors — first report